Last reviewed · How we verify

NCT05448287

Suaahara Impact Evaluation: End-line Survey

Completed Phase 3 Last updated 6 January 2023
What this trial tests

Phase 3 trial testing Health and family planning in Nutritional Stunting in 2,480 participants. Completed in 30 September 2022.

Timeline
17 June 2022
Primary endpoint
30 September 2022
30 September 2022

Quick facts

Lead sponsorUniversity of South Carolina
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment2,480
Start date17 June 2022
Primary completion30 September 2022
Estimated completion30 September 2022
Sites1 location across Nepal

Drugs / interventions tested

Conditions studied

Sponsor

University of South Carolina

Who can join

Adults 0 Months to 60 Months, any sex, with Nutritional Stunting or Feeding Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Suaahara's primary aim is to reduce the prevalence of stunting, wasting, and underweight among children under 5 years of age and to reduce the prevalence of anemia among women of reproductive age and children 6-59 months of age. For this, the program uses a multi-sectoral approach to achieve four key intermediate results: 1) improved household nutrition, sanitation, and health behaviors; 2) increased use of quality nutrition and health services by women and children; 3) improved access to diverse and nutrient-rich foods by women and children; and 4) accelerated roll-out of the Multi-Sectoral Nutrition Plan (MSNP) through strengthened local governance

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of Suaahara, an integrated nutrition programme, on maternal and child nutrition at scale in Nepal.
    Frongillo EA, Suresh S, Thapa DK, Cunningham K, et al · · 2026 · cited 11× · PMID 38342986 · DOI 10.1111/mcn.13630

Verify or expand the search:

Other University of South Carolina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05448287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing